Applied UV Reports Loss of $1.41 Per Share, Misses Revenue Expectations

April 3, 2023

Trending News 🌧️

Applied ($NASDAQ:AUVI) UV, Inc. reported a GAAP EPS of -$1.41 per share, missing expectations by $0.56, and revenue of $20.14M was also lower than anticipated by $0.56M. This news has resulted in a drop in the company’s stock price. Applied UV is a publicly-traded company in the technology industry that focuses on the development of ultraviolet (UV) disinfection products. The company’s products are designed to meet the needs of hospitals, pharmaceutical manufacturers, and food and beverage companies for efficient and safe disinfection. Despite the disappointing results this quarter, Applied UV’s management remains optimistic about their business prospects due to the growth potential of their products. The company believes that the demand for their products will increase as more industries recognize the importance of germ-free environments.

Additionally, they are expanding their product offerings to meet a wider range of needs in the healthcare and food and beverage sectors. Investors should keep a close eye on Applied UV as they continue to build their business and explore new opportunities. The company’s future performance will depend on their ability to capitalize on their strong product offering and make strategic investments in growth areas.

Market Price

After the announcement, the stock opened at $0.9 and closed at $0.9, showing a 3.5% growth from the prior closing price of 0.8. Despite the weak results, investors seemed to welcome the news as the stock remained relatively steady throughout the day. The company has yet to comment on the potential threats posed by their weak performance and whether they plan to take any measures to get back on track. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Applied Uv. More…

    Total Revenues Net Income Net Margin
    20.14 -18.02 -55.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Applied Uv. More…

    Operations Investing Financing
    -8.74 -0.18 2.88
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Applied Uv. More…

    Total Assets Total Liabilities Book Value Per Share
    32.73 15.49 1.03
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Applied Uv are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    29.2% -80.9%
    FCF Margin ROE ROA
    -43.5% -47.3% -31.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has conducted an analysis of the wellbeing of APPLIED UV and has classified it as a ‘cheetah’ company, based on the Star Chart. This type of company has achieved high revenue or earnings growth but is considered less stable due to lower profitability. The health score of APPLIED UV is 6/10, which suggests that the company is likely to pay off debt and fund future operations. When it comes to the individual components, APPLIED UV is strong in growth and profitability, medium in assets and weak in dividends. Given these characteristics of APPLIED UV, we believe that high risk investors may be interested in investing in this company. However, investors should be aware that APPLIED UV may not be as stable as other companies due to its lower profitability. As such, they should proceed with caution when considering investing in this company. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Its competitors are Healthcare Co Ltd, Signature International Bhd, and Kewaunee Scientific Corp.

    – Healthcare Co Ltd ($SHSE:603313)

    The company’s market cap is 4.74B as of 2022. The company’s ROE is -0.51%. The company’s business is providing healthcare services.

    – Signature International Bhd ($KLSE:7246)

    Signature International Bhd is a Malaysia-based investment holding company. The Company’s segments include Property development, which is engaged in the development of residential and commercial properties; Property investment, which is engaged in the holding of investment properties; Hotel operations, which is engaged in the operations of a hotel; and Others, which include provision of management services and trading of building materials. The Company’s subsidiaries include Signature Properties Sdn. Bhd., which is engaged in property development and investment; Signature Hotel Sdn. Bhd., which is engaged in hotel operations; and Wisma Signature Sdn. Bhd., which is engaged in property investment.

    – Kewaunee Scientific Corp ($NASDAQ:KEQU)

    Kewaunee Scientific Corporation is a publicly traded company on NASDAQ with the ticker symbol KEQU. The company is based in Statesville, North Carolina and designs, manufactures, and markets scientific equipment for use in research laboratories and pilot plants worldwide. Kewaunee Scientific’s primary product lines are fume hoods, casework, and adaptable modular systems used in a variety of scientific applications. The company also provides related services, including installation and after-market support.

    Summary

    Applied UV Inc. is an innovative technology company specializing in ultraviolet disinfection products. Its recent earnings report showed a negative GAAP EPS of -$1.41 and revenue of $20.14M, both missing expectations by $0.56 and $0.56M respectively. Despite the miss, the stock price moved up on the same day. As such, Applied UV could be a promising investment for those seeking growth potential in this sector.

    Recent Posts

    Leave a Comment